OUTCOMES |
Type of outcome
|
Outcome
|
Timepoint(s) at which outcome measured
|
Primary Outcome |
Changes in self-reported depression symptoms as measured by the Patient Health Questionnaire - 8 |
Baseline and 2-week follow-up. |
Primary Outcome |
Changes in self-reported anxiety symptoms, measured by the Generalized Anxiety Disorder Screener - 7 |
Baseline and 2-week follow-up |
Secondary Outcome |
Changes in perceived academic control, measured by the Perceived Control Scale for Children - Academic sub scale. |
Baseline and 2-week follow-up. |
Secondary Outcome |
Changes in self-reported optimism, as measured by the EPOCH Measure of Adolescent Well-Being - Optimism sub scale |
Baseline and 2-week follow-up. |
Secondary Outcome |
Changes in self-reported happiness, as measured by the EPOCH Measure of Adolescent Well-Being - Happiness subscale. |
Baseline and 2-week follow-up. |
Primary Outcome |
Changes in self-reported mental well-being as indicated by the The Short Warwick–Edinburgh
Mental Well-being Scale (SWEMWBS) |
Baseline and 2-week follow-up. |
Secondary Outcome |
Changes in self-reported depression symptoms as measured by the PHQ-8 for participants who meet a clinical cut-off for depression and anxiety symptoms - clinical cutoff will be determined by a score of 10 or greater on the GAD-7 or a score of 15 or greater on the PHQ-8 |
Baseline and 2-week follow-up. |
Secondary Outcome |
Changes in self-reported anxiety symptoms as measured by the GAD-7 for participants who meet a clinical cut-off for depression and anxiety symptoms - clinical cutoff will be determined by a score of 10 or greater on the GAD-7 or a score of 15 or greater on the PHQ-8 |
Baseline and 2-week follow-up. |
Secondary Outcome |
Moderator analysis on primary outcomes with level of anxiety symptoms as a continuous moderator. |
Baseline and 2-week follow-up. |
Secondary Outcome |
Moderator analysis on primary outcomes with level of depression symptoms as a continuous moderator. |
Baseline and 2-week follow-up. |
Secondary Outcome |
Moderator analysis on primary outcomes with level of anxiety symptoms as a categorical moderator - categories will be no-anxiety, 0-4 on GAD-7, mild-anxiety, 5-9 on the GAD-7, and moderate-to-severe anxiety, 10 or greater on the GAD - 7 . |
Baseline and 2-week follow-up |
Secondary Outcome |
Moderator analysis on primary outcomes with level of depression symptoms as a categorical moderator - categories will be defined as minimal-or-none depression, defined as 0-4 on the PHQ-8, mild depression, defined as 5-9 on the PHQ-8, moderate depression, defined as 10-14 on the PHQ-8, moderately severe-to-severe depression, defined as greater than 15 on the PHQ-8. |
Baseline and 2-week follow-up |